The year 2022 saw multiple crises: an ongoing pandemic, extreme heat waves and drought, war in Ukraine, inflation and an energy crisis—all reminders of the importance of addressing the global determinants of health in a multidisciplinary way, with equity as a guiding principle.
Much work lies ahead, but we are proud of our achievements and deeply grateful for the dedication and excellence of our ISGlobal colleagues, through thick and thin. In 2022, we kept up the pace with 585 scientific publications (87% in Q1 journals), 18 patents granted and 3 software registered, and 114 newly-funded projects. We trained 1,360 students and appeared over 8,600 times in the media. Our total budget reached a record of €49 million (84% from competitive funding), supporting the largest growth in our staff, with 541 people from 47 different nationalities by the end of 2022.